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Congenital anomalies of the kidneys and urinary tract (CAKUT) are the most common cause of chronic kidney disease in the first three
decades of life. Identification of single-gene mutations that cause CAKUT permits the first insights into related disease mechanisms.
However, for most cases the underlying defect remains elusive. We identified a kindred with an autosomal-dominant form of CAKUT
with predominant ureteropelvic junction obstruction. By whole exome sequencing, we identified a heterozygous truncating mutation
(c.1010delG) of T-Box transcription factor 18 (TBX18) in seven affected members of the large kindred. A screen of additional families
with CAKUT identified three families harboring two heterozygous TBX18 mutations (c.1570C>T and c.487A>G). TBX18 is essential
for developmental specification of the ureteric mesenchyme and ureteric smooth muscle cells. We found that all three TBX18 altered
proteins still dimerized with the wild-type protein but had prolonged protein half life and exhibited reduced transcriptional repression
activity compared to wild-type TBX18. The p.Lys163Glu substitution altered an amino acid residue critical for TBX18-DNA interaction,
resulting in impaired TBX18-DNA binding. These data indicate that dominant-negative TBX18 mutations cause human CAKUT by
interference with TBX18 transcriptional repression, thus implicating ureter smooth muscle cell development in the pathogenesis
of human CAKUT.Introduction
Chronic kidney disease (CKD) takes a high toll on human
health, requiring dialysis or kidney transplantation for sur-
vival. Congenital anomalies of the kidneys and urinary
tract (CAKUT) are the most frequent cause of CKD in the
first three decades of life, accounting for 40%–50% of all
cases.1 CAKUT occurs in about 3 to 6 per 1,000 live births
and constitutes 20%–30% of all birth defects identified in
the neonatal period.2–4 No prophylaxis is available. Recent
identification of monogenic mutations in genes that
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It has been hypothesized that many forms of CAKUT in
humans are probably caused by rare single-gene defects,10
based on multiple lines of evidence. (1) A large number of
monogenic mouse models of CAKUT were reported,10 and
many of the related genes participate in nephrogenesis.2,11
(2) By devising a high-throughput exon sequencing tech-
nique,12 we previously showed that causative mutations
in 12 different genes can be identified in about 10% of
case subjects with CAKUT.6–8 However, extensive genetic
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very difficult.7,8,10 Most known single genes that cause CA-
KUT if mutated are inherited in an autosomal-dominant
manner and exhibit the clinical genetic features of incom-
plete penetrance and variable expressivity.7,10
CAKUT in humans as well as in many mouse models
might cover a wide spectrum of urinary tract malforma-
tions that ranges from mild to severe phenotypes
including unilateral vesicoureteral reflux and bilateral
renal agenesis. This spectrum can be found in different in-
dividuals of the same family with CAKUT, or between both
kidneys of the same individual, even if the causative single-
gene mutation is identical. Because this variability in
anomalies of the kidneys and the lower urinary tract can
be inseparable, the term ‘‘congenital anomalies of the kid-
neys and urinary tract’’ was coined.13 The phenotypic vari-
ability of CAKUT in the presence of an identical mutation
might be due to stochastic gene dosage effects of the tran-
scription factors involved. Alternatively, it might be caused
by a so-called genetic ‘‘sequence,’’ in which the primary ge-
netic defect causes urinary tract obstruction, which then
mechanically leads to developmental defects like renal hy-
podysplasia.13
To gain further insights into the pathogenesis of CAKUT,
we investigated a four-generation family by whole exome
sequencing (WES) as well as 1,295 unrelated individuals
with CAKUT. We here identify dominant-negative muta-
tions in the transcription factor TBX18 gene as causing
human CAKUT via lack of repression of TBX18 transcrip-
tional activity, thereby implicating ureter smooth muscle
cell development in the pathogenesis of human CAKUT.Methods
Study Participants
After informed consent, we obtained clinical data, pedigree data,
and blood samples from individuals with CAKUT from worldwide
sources via a standardized questionnaire. Approval for human sub-
jects’ research was obtained from the Institutional Review Boards
of the University of Michigan, Boston Children’s Hospital, and
Massachusetts General Hospital and from relevant local ethics re-
view boards. Informed consent was obtained from the individuals
and/or parents, as appropriate. The diagnosis of CAKUTwas made
by (pediatric) nephrologists and/or urologists based on relevant
imaging.Whole Exome Sequencing
To identify a causative mutated gene for CAKUT, we investigated
family members from a four-generation white Hispanic family in
the USA with an autosomal-dominant form of CAKUT predomi-
nantly characterized by ureteropelvic junction obstruction
(UPJO) and hydronephrosis (Table 1). DNA samples from three
affected distant cousins (Figure 1A) were subjected to whole
exome sequencing (WES) as established previously via Agilent
SureSelect human exome capture arrays (Life Technologies) with
next-generation sequencing (NGS) on an Illumina sequencing
platform. Sequence reads were mapped against the human refer-
ence genome (NCBI build 37/hg19) using CLC Genomics Work-
bench (v.6.5.1) software (CLC bio). Mutation calling under an292 The American Journal of Human Genetics 97, 291–301, August 6autosomal-dominant model was performed by geneticists and
cell biologists, who had knowledge regarding clinical phenotypes,
pedigree structure, genetic mapping, and WES evaluation (Table
S1) and in line with proposed guidelines.14,15 Sequence variants
that remained after the WES evaluation process were examined
for segregation in seven affected and seven unaffected family
members.
Whole Exome Sequencing Analysis
AfterWES, genetic variants were first filtered to retain only hetero-
zygous, non-synonymous variants that were shared between the
three affected relatives of family A3880 subjected to WES. Second,
filtering was performed to retain only alleles with a minor allele
frequency (MAF) < 0.1%, a widely accepted cutoff for auto-
somal-dominant disorders.16,17 MAF was estimated using com-
bined datasets incorporating all available data from the 1000
Genomes Project, the Exome Variant Server (EVS) project,
dbSNP138, and the Exome Aggregation Consortium (ExAC).
Third, observed sequence variants were analyzed with the UCSC
Human Genome Bioinformatics Browser for the presence of paral-
ogous genes, pseudogenes, or misalignments. Fourth, we scruti-
nized all variants with MAF < 0.1% within the sequence align-
ments of the CLC Genomic Workbench software program for
poor sequence quality and for the presence of mismatches that
indicate potential false alignments. Fifth, we employed web-based
programs to assess variants for evolutionary conservation, to
predict the impact of disease candidate variants on the encoded
protein, and to predict whether these variants represented known
disease-causing mutations. Finally, Sanger sequencing was per-
formed to confirm the remaining variants in original DNA samples
and to test for familial segregation of phenotype with genotype
Analysis of Copy-Number Variants
For two individuals from the index family (IV3 and IV6 from fam-
ily A3880; Figure 1A), genome-wide genotyping for copy-number
variant (CNV) analysis was performed on an Illumina platform as
previously described.18 Genotype calls and quality-control ana-
lyses were performed with Genome Studio v.2010.3 (Illumina)
and PLINK software. The CNV calls were determined with general-
ized genotypingmethods implemented in the PennCNV program.
CNVs were mapped to the human reference genome hg18 and an-
notated with UCSC RefGene and RefExon (CNVision program25).
High-Throughput TBX18 Mutation Analysis
Massively parallel sequencing of TBX18 exons was performed in
1,589 individuals from 1,295 different families affected by CAKUT
from different pediatric nephrology centers worldwide using
microfluidic PCR (Fluidigm) and next-generation sequencing
(MiSeq, Illumina) as described previously.7,12,19 Variants were
filtered against public variant databases (EVS) and only novel
heterozygous variants were considered, confirmed by Sanger
sequencing, and tested for segregation with the CAKUT pheno-
type. Variants were also tested for absence from in-house control
populations of 448 individuals with steroid-resistant nephrotic
syndrome and 712 individuals with nephronophthisis.
Immunohistochemistry
Epitope retrieval on paraffin-embedded sections of mouse tissue
was performed with OmniPrep Solution (pH 9.0) from ZYTOMED
Systems. After quenching of endogenous peroxidases (10 min
with 3% H2O2), the goat-derived polyclonal antibody (AB), 2015
Table 1. Dominant TBX18 Mutations Detected in Individuals with Obstructive Uropathy and Other Forms of CAKUT
Family-
Individual Ancestry
Nucleotide
Alterationa
Exon
(Zygosity)
Alteration
in Coding
Sequencea,b
Continuous AA
Sequence
Conservationc,d
Allelic Loss
of Function
(half-life/
lucif/EMSA)a,e
Presenting
Symptoms
(at Age in Years) Kidney Phenotype Treatment
Serum
Creatinine
(mg/dl) (at
Age in Years)
A3880-II1 Hispanic (USA) c.1010delG 7 (het) p.Gly337Valfs*19 protein truncating
mutation
(þ/þ/) back pain (13) bilateral upjo left kidney
surgery
1.06 (52)
A3880-II4 c.1010delG p.Gly337Valfs*19 (þ/þ/) flank pain (43) bilateral upjo ureteral stent
placement,
unilateral
nephrectomy
0.8 (68)
A3880-III5 c.1010delG p.Gly337Valfs*19 (þ/þ/) flank pain (17) left upjo ureteral stent
placement
0.8 (42)
A3880-III9 c.1010delG p.Gly337Valfs*19 (þ/þ/) hematuria (49) bilateral
hydronephrosis
conservative 0.68 (50)
A3880-IV1 c.1010delG p.Gly337Valfs*19 (þ/þ/) hydronephrosis
(prenatal)
bilateral
hydronephrosis
conservative 0.36 (6)
A3880-IV3 c.1010delG p.Gly337Valfs*19 (þ/þ/) urinary tract
infection (1)
bilateral uvjo bilateral ureteral
reimplantation,
unilateral
nephrectomy
0.7 (37)
A3880-IV6 c.1010delG p.Gly337Valfs*19 (þ/þ/) flank pain (8) unilateral upjo unilateral
nephrectomy
0.98 (26)
A2900-I2 f Albanian c.1570C>T 8 (het) p.His524Tyr Danio rerio (þ/þ/) asymptomatic (28) renal duplex and
asymmetry
conservative 0.8 (28)
A2900-II1 hydronephrosis
(prenatal)
megaureter and
ureterocele
ureteral
reimplantation
0.4 (6)
A2900-II2 asymptomatic (6) renal asymmetry conservative 0.55 (6)
A2385-II1 Albanian c.1570C>T 8 (het) p.His524Tyr Danio rerio (þ/þ/) asymptomatic (13) bilateral small
kidneys
renal
transplantation
ESKD (13)
ICH_006-
D80240
British c.487A>G 2 (het) p.Lys163Glu Danio rerio (þ/þ/þ) bilateral small
echogenic kidneys
(prenatal)
left VUR III, bilat.
renal dysplasia
NA ESKD
Abbreviations are as follows: CKD, chronic kidney disease; ESKD, end-stage kidney disease; het, heterozygous; NA, not applicable; ND, no data; UPJO, ureteropelvic junction obstruction; UVJO, ureterovesical junction obstruc-
tion VUR, vesicoureteral reflux.
acDNA mutations are numbered according to human cDNA reference sequence GenBank: NM_001080508.1, isoform (TBX18), where þ1 corresponds to the A of ATG start translation.
bAll mutations had a PolyPhen-2 (PP2) humvar score of functional ‘‘deleteriousness’’ of 1.0.
cAltered amino acid (aa) residues were conserved throughout vertebrates (see Figure S2).
dAll mutations were absent from 712 control individuals with renal ciliopathies, 448 individuals with steroid-resistant nephrotic syndrome, ~13,000 healthy control alleles of the EVS, 2,577 control individuals of the 1000
Genomes project, and ~112,000 control chromosomes of the ExAC server with the exception of p.His524Tyr, which is reported twice heterozygously in ~120,000 controls.
ePlus sign (þ) indicates a defect of the allele in one of the three assays of TBX18 function: protein half-life (Figure 2B), luciferase assay (Figure 2C), or EMSA (Figure 3C).
fFamily A2900 included an unaffected sibling who does not carry the mutation.
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Figure 1. Identification of TBX18 Muta-
tions in the Index Family A3880 and Three
Additional Families with CAKUT
(A) Pedigree of index family A3880.
Squares represent males, circles females,
black symbols affected persons, and white
symbols unaffected persons. All affected
family members presented with obstruc-
tive uropathy. Pedigree is compatible
with an autosomal-dominant mode of
inheritance. Roman numerals denote
generations. Individuals are numbered
with Roman numerals if DNA was
available for study. The arrow points to
the proband IV3. WT denotes the wild-
type allele. p.Gly337Valfs*19 indicates
the mutation c.1010 deletion of G in
TBX18, leading to a frameshift muta-
tion and introducing a premature stop
codon 19 codons downstream. The muta-
tion fully segregated heterozygously
(WT/p.Gly337Valfs*19) across all seven
affected individuals examined and was
absent from all seven unaffected family
members available for study (WT/WT).
Red circles indicate the persons selected
for whole exome sequencing.
(B) Abdominal CT scan of the index indi-
vidual A3880-IV3 revealing severe bilateral
hydronephrosis (white asterisks) second-
ary to bilateral ureteral obstruction. The
index individual presented during infancy
and was diagnosed after evaluation of
urinary tract infection. She underwent
corrective surgery with multiple consecu-
tive reconstructive operations to her lower
urinary tract. She had no extrarenal mani-
festations.
(C) Prenatal renal US of individual A3880-
IV1 with bilateral hydronephrosis at a
gestational age of 28 weeks. Postnatally,
he had unilateral pelviectasis (Figure S1A)
with normal voiding cysturethrogram.
At the age of 6.5 years there was left-sided
renal hypodysplasia with no signs of
obstruction (Figures S1B and S1C).
(D) Exon structure of human TBX18 cDNA
and domain structure of the T-box domain
18 (TBX18) protein. TBX18 contains a
nuclear localization signal (NLS, red); an
engrailed homology-1 motif (EH1, blue),
and a DNA-binding T-box domain (yel-
low). Start codon (ATG) and stop codon
(TGA) are indicated.
(E) Chromatograms of heterozygous mutations detected in TBX18 (in relation to exons and protein domains) in the index family (red)
and three additional families (black) with CAKUT. The index family’s heterozygous mutation c.1010delG leads to a frameshift and after
19 amino acids to a premature termination codon (p.Gly337Valfs*19).TBX18 (C-20) (sc-17869 from Santa Cruz) was used for immunode-
tection at 1:100 dilutions. Blocking solution and peroxidase-
conjugated anti-goat secondary AB were used from the VECTOR
ImmPRESS reagent Kit. The VECTOR Peroxidase Substrate Kit
ImmPACT DAB was used for the final peroxidase-mediated color
reaction.
Cell Culture, Transient Transfections, and Reporter
Assays
HEK293 cells were seeded at 20%–30% confluency in Dulbecco’s
modified Eagle’s medium, supplemented with 10% fetal calf294 The American Journal of Human Genetics 97, 291–301, August 6serum, grown overnight, and transfected by the calcium phos-
phate method. For reporter assays (Dual luciferase reporter assay
system, Promega), HEK293 cells were seeded in 6-well dishes and
transfected with constant amounts of reporter plasmids and
100 ng of pRL-TK Renilla Luciferase (kind gift from A. Gossler)
for normalization. The total amount of expression plasmid was
kept constant by adding empty pcDNA3. Per transfection,
500 ng of pGL3.Tbx18BS-luciferase reporter plasmid (which har-
bors two T-half sites as inverted repeats: 50-AGGTGTGAAAT
CGCACCT-30) and 500 ng of prK5.Myc.TBX18 expression plas-
mids were used. For competition experiments, the amount of, 2015
prK5.Myc.TBX18_WT was held constant and prK5.Myc.TBX18_
p.G337Vfs*19 was added with increasing amounts. Firefly lucif-
erase and Renilla luciferase activities were measured 24 hr after
transfection. All transfections were performed in duplicate, and
experiments were repeated at least three times. After normaliza-
tion, the mean luciferase activities and standard deviations were
plotted as ‘‘fold activation’’ when compared with the empty
expression plasmid. p values were determined with the Student’s
t test.Immunofluorescence
Experiments in HEK293 cells were performed according to stan-
dard protocols. Primary antibodies used were rat anti-HA (3F10,
Roche Applied Science) and mouse anti-myc (9E10, Sigma), both
at 1:250 dilutions. Secondary antibodies were donkey anti-rat
IgG (HþL) fluorescein isothiocyanate and donkey anti-mouse
IgG(HþL) rhodamine (both Dianova) at 1:250 dilutions. Immuno-
fluorescent detection of proteins was repeated at least three times,
and representative examples were photographed on a Leica
DM6000 microscope with DFC350FX camera (Leica).Half-Life Estimation
HEK293 cells were cultured and transfected as described above. At
48 hr post-transfection, 10 mg ml1 cycloheximide (Sigma) was
added and cells were incubated for the indicated time points. After
incubation, cells were trypsinized and counted. Per 12,000 cells,
1 ml of lysis buffer (5 mM Tris [pH 7.5], 80 mM NaCl, 50 mM
NaF, 1 mM MgCl2, 0.1% Nonidet P-40, 1 tablet/10 ml Complete
Mini EDTA-free protease inhibitor Cocktail) was added. Protein
levels were analyzed by immunoblotting with specific antibodies.
The half-life was calculated with GraphPad Prism (v.4) with the
following parameters: Nonlinear Regression (Curve Fit); Build-in
model: Exponential; Equation: One phase decay.Electrophoretic Mobility Shift Assay
Proteins used for electrophoretic mobility shift assay (EMSA) were
generated from prK5.Myc.TBX18 expression constructs for TBX18
wild-type and mutant proteins using the SP6-coupled TNT Wheat
Germ Extract System (Promega) for SP6-directed in vitro transla-
tion according to the supplier’s instructions. To generate a probe
harboring two inverted T-half sites oligonucleotides BS.invF,
50-GATCCACAGGTGTGAAATTTCACACCTACC-30 and BS.invR,
50-TCGAGGTAGGTGTGAAATTTCACACCTGTG-30 were boiled
for 5 min and cooled slowly down to room temperature to anneal.
The annealed oligonucleotides were subcloned as BamHI/NcoI
fragments into pKS vector (Stratagene) and released by BamHI/
AseI as a 214 bp fragment. The fragment was dephosphorylated
with Antarctic Phosphatase (New England Biolabs) for 1 hr at
37C. The fragments were end-labeled with T4-PNK (New England
Biolabs) in the presence of [g-32P]ATP. Binding reactions for gel
shift assays contained 2–5 ml of in vitro translated myc-tagged
protein in a total volume of 20 ml of HEPES buffer (25 mM HEPES
[pH 7.4], 10% glycerol, 75 mM NaCl, 0.25 mM EDTA, 1 mM
MgCl2, 0.1% Nonidet P-40, 10 mg/ml BSA, 1 mM DTT) with 1
tablet/10 ml Complete Mini EDTA-free protease inhibitor Cocktail
(Roche Applied Science) and 1.5 mg of double-stranded poly(dI-dC)
(Roche). Reactions were preincubated for 20 min on ice before
15,000 counts of probe were added. For supershift experiments,
1.5 ml of anti-myc antibody (9E10, Sigma) was added to the lysate.
Complexes were allowed to form at room temperature for 20 min,
before the reactions were loaded on a native 4% polyacrylamideThe Amergel (0.53 Tris-borate-EDTA). Gels were run at 20 V/cm for 5 min
and then decreased to 10 V/cm for 2–4 hr at 4C before they
were dried and exposed to imaging plate (Fujifilm).
Co-immunoprecipitation Assays
Myc- or HA-tagged prey proteins were produced by in vitro trans-
lation of full-length cDNAs cloned in pSP64 vectors (Promega TnT
SP6). The binding reactionwas performed in HEPES buffer (25mM
HEPES [pH 7.4], 10% glycerol, 75 mM NaCl, 1 mM MgCl2, 0.1%
Nonidet P-40, 10 mg/ml BSA, 1 mM DTT) for 1 hr at 4C. Protein
G Sepharose beads (GE Healthcare) were preblocked with 1%
BSA for 1 hr at room temperature. 2 ml of anti-Myc antibody and
25 ml of protein G Sepharose were added to the supernatant for
2 hr at 4C, before the beads were washed three times with
500 ml of HEPES buffer. Proteins were eluted from the beads by
boiling in loading buffer for 5 min and were analyzed by immuno-
blot with anti-myc-HRP (Abcam ab62928) and anti-HA-HRP
(Abcam ab1265) antibodies, and 10% of the input was loaded as
a control.Results
TBX18 Mutations Cause CAKUT
To identify a causative mutated gene for CAKUT, we inves-
tigated a four-generation Hispanic family of ten individ-
uals with congenital anomalies of the kidneys and urinary
tract (CAKUT). Ureteropelvic junction obstruction (UPJO)
was predominant together with hydronephrosis and/or
vesicoureteral junction obstruction (Figures 1A–1C and
S1; Table 1). Five of the seven affected individuals available
for study required surgical intervention to relieve obstruc-
tion. Age at diagnosis ranged from the prenatal period to
adulthood. None of the affected individuals had extra-
renal malformations or syndromic features. There were
seven unaffected family members available to the study
that had normal urinary tract imaging. Pedigree structure
was compatible with autosomal-dominant or X-linked
segregation of CAKUT (Figure 1A).
Under the hypothesis that mutation of an autosomal-
dominant gene causes CAKUT in this family, we selected
three distant cousins (affected individuals A3880-II1,
-IV3, and -IV6) for whole exome sequencing (WES). Given
the pedigree structure (Figure 1A), the three affected
individuals are expected to share about 3.125% of all
alleles by descent, allowing us to reduce 32-fold the
thousands of variants from normal reference sequence
that are expected to result fromWES (Table S1).20 We iden-
tified a heterozygous truncating mutation (c.1010delG
[p.Gly337Valfs*19]) in T-Box transcription factor 18 (TBX18)
(MIM: 604613; GenBank: NM_001080508.1) (Table 1 and
Figures 1D and 1E). Segregation analysis revealed that
this mutation was shared by all seven available affected
family members and was absent from all seven unaffected
familymembers available for study (Figure 1A and Table 1).
The LOD score resulting from this segregation pattern
(Zmax ¼ 4.2) represents significant linkage (Zmax > 3.3),
thereby rendering it extremely likely that the TBX18
truncating mutation causes CAKUT in this family.ican Journal of Human Genetics 97, 291–301, August 6, 2015 295
Furthermore, the mutation was absent from 104 ethnically
matched controls, from all available databases (Table 1), as
well as from two in-house control cohorts of 480 and 768
individuals with nephrotic syndrome and nephronophthi-
sis, respectively. We also showed by CNV analysis that the
affected individuals lacked heterozygous deletions that
have previously been associated with CAKUT in the
HNF1B locus and the DiGeorge/velocarodiofacial syn-
drome locus.18
We next performed highly parallel exon sequencing12,19
of all eight TBX18 exons in 1,295 unrelated individuals
with CAKUT. We detected four additional heterozygous
missense mutations (c.1570C>T [p.His524Tyr], c.487A>G
[p.Lys163Glu], c.490G>A [p.Ala164Thr], and c.1576C>T
[p.Pro526Ser]) in five unrelated families with CAKUT
(Table 1 and Figures 1D and 1E). All mutations met strict
genetic criteria regarding their functional deleteriousness
(Table 1). Specifically, all mutated amino acid residues
were fully conserved among vertebrates that possess
TBX18 orthologs (Table 1; Figure S2). All mutations were
absent from >13,000 healthy control alleles in the EVS
database (Table 1). Because the two genetic variants
p.Ala164Thr and p.Pro526Ser did not exhibit loss of func-
tion in any of the functional evaluations described below,
we did not consider them as disease causing and will not
show the related functional data (data available from the
authors).
TBX18 Mutations Interfere with Transcriptional
Repression
Tbx18 is a member of the Tbx1 subfamily of T-box tran-
scription factor genes expressed at multiple sites during
embryogenesis in the mouse.21 In the urogenital system,
expression is confined to the undifferentiated mesen-
chyme surrounding the distal ureter. In Tbx18/ mice,
descendants of former Tbx18-positive cells do not differen-
tiate into smooth muscle cells of the ureter but mislocalize
to the kidney and differentiate into fibroblast-like cells.
As a consequence, the renal pelvis becomes dramatically
enlarged at the expense of the ureter, and hydronephrosis
develops at birth.22,23 We show by immunohistochemistry
that TBX18 localizes to the renal pelvic and ureteral
smooth muscle cells (Figure S3).
Previous biochemical analysis showed that the murine
TBX18 protein harbors in the N-terminal region a nuclear
localization signal (NLS) and an engrailed homology 1
(EH1) domain that mediates transcriptional repression by
binding to the WD40 domain of Groucho/TLE transcrip-
tional corepressors (Figure 1D). The downstream T-box
domain binds to combinations of cognate DNA binding
sites, so-called ‘‘T-half-sites.’’ The T-box also confers pro-
tein interaction with TBX18 itself (i.e., homodimerization)
and with a number of other tissue-specific transcription
factors including NKX2.5, PAX3, GATA4, and SIX1.24,25
Interaction with SIX1, mutation of which causes bran-
chio-oto-renal syndrome with CAKUT in humans,9 is
important for mediating ureteric smooth muscle forma-296 The American Journal of Human Genetics 97, 291–301, August 6tion in concert with TBX18.26 No function has yet been
assigned to the large C-terminal region of TBX18.
To examine how the c.1010delG (p.Gly337Valfs*19)
mutation, which segregated with the CAKUT phenotype
in the large family A3880, conveys TBX18 loss of function,
we evaluated TBX18 for its known protein domain-related
functional features. These include (1) nuclear localization
via its NLS, (2) homodimerization, (3) transcriptional
repression, (4) DNA interaction via its T-box domain, and
(5) interaction with Groucho/TLE and SIX1.
Transfection of expression constructs in HEK293 cells
revealed that, whereas a control construct lacking the
NLS did not localize to nucleus, the altered forms of
TBX18 (p.Gly337Valfs*19, p.His524Tyr, and p.Lys163Glu)
do localize to the nucleus as does the wild-type protein
(Figure 2A). Furthermore, all three mutant proteins (that
still contained an intact NLS sequence) mediated nuclear
localization of a variant of TBX18 lacking the nuclear
localization signal (NLS),24 most likely by dimerization
with it, indicating that the mutations do not perturb sub-
cellular localization or homodimerization of the TBX18
protein (Figure 2A). We thereby established that the
three TBX18 mutants still dimerize and traffic to the nu-
cleus, suggesting a dominant-negative pathomechanism
rather than haploinsufficiency. Furthermore, all three
mutations affected the half-life of the encoded proteins
(Figure 2B). Whereas the half-life of wild-type TBX18 was
determined to be 2.5 hr in vitro, the half-lives of the
mutant proteins were considerably prolonged to more
than 30 hr (p.Gly337Valfs*19), 15 hr (p.His524Tyr), and
4 hr (p.Lys163Glu) (Figure 2B), consistent with a domi-
nant-negative effect of all three altered proteins.
We next determined whether the mutations affected
the transcriptional activity of TBX18 protein by using
cotransfections of TBX18 expression plasmids and a
pGL3 reporter plasmid harboring two inverted repeats
of T half sites (50-AGGTGTGAAATCGCACCT-30). A wild-
type TBX18 expression construct mediated transcriptional
repression to 58% in this assay, whereas three mutant con-
structs (p.Gly337Valfs*19, p.His524Tyr, and p.Lys163Glu)
showed significantly less repressive activity (Figure 2C).
In addition, co-transfection of TBX18 wild-type construct
with the protein truncating construct p.Gly337Valfs*19
in increasing amounts yielded a dose-dependent lack of
repression, supporting a dominant-negative effect of the
mutant protein on transcriptional activity of the wild-
type protein.
The p.Lys163Glu Substitution Alters TBX18-DNA
Interaction
The T-box domain of TBX18 is known to directly interact
with cognate sequences on genomic DNA at specific
transcription sites. Interestingly, the amino acid residue
Lys163, which is altered in individual ICH_006 with
CAKUT, resides within the TBX18 T-box domain and is
fully conserved in all the H. sapiens TBX paralog proteins
(Figures 3A, 3B, and S2). The structures of the T-box, 2015
Figure 2. Trafficking of TBX18 to Nuclei
via Its Nuclear Localization Signal,
Prolonged Half-Life of Mutant Proteins,
and Lack of Transcriptional Repression
by TBX18 Mutants
(A) Immunofluorescence images in
HEK293 cells that were cotransfected with
an HA-tagged construct (TBX18del_NLS_
HA) that lacks the nuclear localization
signal (green), together with either (red) a
human Myc-tagged labeled TBX18 wild-
type construct (Myc.TBX18_WT) or con-
structs representing the substitution of
family A3880 (Myc.TBX18_Gly337Valfs*
19), the substitution of families A2900
and A2385 (Myc.TBX18_His524Tyr), or
the substitution of family ICH_006
(Myc.TBX18_Lys163Glu). Note that the
NLS-deficient construct TBX18del_NLS_
HA fails to localize to the nucleus (left
column). However, in the presence of co-
transfection of either Myc.TBX18_WT
or either altered protein (red), even the
NLS-deficient proteins (green) traffic to
the nucleus, most likely by T-box-mediated
dimerization with the NLS-containing
Myc-tagged construct (red). Double-trans-
fected cells (HA-construct and Myc-
construct) are denoted by arrowheads.
(B) Half-life estimation of wild-type
and mutant TBX18. Although the half-life
of wild-type TBX18 was determined to
be 2.5 hr in vitro, the half-lives of the
mutant proteins were prolonged to more
than 30 hr (p.Gly337Valfs*19), 15 hr
(p.His524Tyr), and 4 hr (p.Lys163Glu).
(C) Luciferase transcriptional reporter
assay for TBX18 wild-type and mutant
constructs. Compared to empty vector
control (set at 100% of luciferase activity),
transfection with TBX18 wild-type
construct causes transcriptional repres-
sion to 58%. All three mutant constructs
(p.Gly337Valfs*19, p.His524Tyr, and
p.Lys163Glu) detected in CAKUT-affected
families repressed transcriptional activity
significantly less than the wild-type construct. Co-transfection of TBX18 wild-type construct and the protein truncating construct
p.Gly337Valfs*19 in increasing amounts yielded a dose-dependent lack of repression for the mutant construct, supporting its domi-
nant-negative effect on transcriptional repression by the wild-type construct. *p < 0.05, **p < 0.01.domains of TBX1, TBX3, TBX5, and brachury from X. laevis
were previously solved.27 Intriguingly, the equivalent of
TBX18 Lys163 was shown to interact with the phosphate
sugar backbone of the cognate DNA sequence.28 Because
reduced transcriptional repression can derive from
impaired DNA binding of altered TBX18, we tested by elec-
trophoretic mobility shift assay (EMSA) whether any of the
mutations that we found in families affected by CAKUT
interfered with DNA binding of the T-box (Figures 3A–
3C). As predicted from the structural model, electropho-
retic mobility shift assay (EMSA) employing TBX18 bind-
ing sites and in vitro translated proteins showed that the
TBX18 substitution p.Lys163Glu no longer bound to its
cognate site on DNA, whereas p.Gly337Valfs*19 and
p.His524Tyr bound to the site, as did the wild-type
TBX18 protein (Figure 3C). Reduced transcriptional repres-The Amersion might also stem from impaired interaction with other
transcription factors and/or transcriptional corepressors.
However, cotransfection/coimmunoprecipitation experi-
ments revealed that all three altered proteins still bound
to SIX1 and Groucho corepressor TLE3 (Figure S4),24 sug-
gesting that other transcription factors might be involved.
CAKUT Phenotype in Tbx18þ/ Mice
Previous work reported that mice homozygous for a null
allele of Tbx18 show hydroureter and hydronephrosis. To
describe the phenotypic quality and penetrance of these
changes in more detail, we re-inspected a large number of
both heterozygous and homozygous Tbx18-deficient mice
that we published previously.23 In 74% of newborn em-
bryos homozygous for a null allele of Tbx18 (n ¼ 23), we
detected UPJO; the remaining 26% featured a bilateralican Journal of Human Genetics 97, 291–301, August 6, 2015 297
Figure 3. Three-Dimensional Model of
Crystal Structure of Human TBX18 Paralog
TBX1 in Complex with Cognate DNA
(A) Ribbon diagram of the TBX1-DNA com-
plex in orthogonal views. Depicted are res-
idues of two TBX18 monomers. b-pleated
sheets are marked as yellow arrows, a heli-
ces in red, and DNA is marked in white as
space-filling model. Residues marked in
blue are those found at the protein-DNA
interface (see B). Arrows point to the posi-
tion of the amino acid residue Lys163
(red) found altered (p.Lys163Glu) in family
ICH_006 with CAKUT. Inset on the right
shows that Lys163 (arrow pointing to red
Lys163 side chain) is in direct vicinity to
the DNA interaction interface (white)
(modeled in TBX1, PDB: 4A04).
(B) Partial sequence alignment of TBX18
T-box domain and its paralogs, for which
protein 3D crystal structure data are avail-
able (H. sapiens TBX1, TBX3, and TBX5
and X. laevis brachyury). Amino acid resi-
due numbers are shown per alignment
row. Residues in blue are in the vicinity of
the TBX1 protein-DNA interface (see A).
Residue Lys163 found altered (p.Lys163
Glu) in family ICH_006 with CAKUT is
shown in red.
(C) DNA binding assay of wild-type TBX18
andTBX18mutants detected in individuals
with CAKUT show that p.Lys163Glu sub-
stitution fails to bind to DNA. Electropho-
retic mobility shift assay (EMSA) was per-
formed with equal amounts of in vitro
synthesized myc-tagged constructs Myc.
TBX18_wild-type (wild-type), Myc.TBX18_
Gly337Valfs*19,Myc.TBX18_His524Tyr, or
Myc.TBX18_Lys163Glu. All alleles except
for p.Lys163Glu bind to the TBX18 DNA
target site as indicated by retardation of
the labeled probe (red arrowheads in lanes
3). Specificity of the binding is confirmed
by the addition of anti-myc antibody that
results in formation of a super shifted com-
plex (black arrowheads in lanes 5).hydroureter. Interestingly, we found that only 7% of
Tbx18þ/ (n ¼ 41) heterozygous mice had a mild proximal
hydroureter, confirming the recessive nature of the null
mutation and demonstrating only a very minor role for
haploinsufficiency. This further confirms that the muta-
tions identified in humans with CAKUT exert a dominant-
negative effect rather than haploinsufficiency of these
alleles. These findings might also explain why in humans
withCAKUTdominantTBX18mutations are so infrequent,
because a dominant-negative effect usually results from
only a few very specific amino acid changes, and because
the mice with recessive mutations were perinatal lethal
and our cohort did not include such severe phenotypes.23Discussion
We here identify dominant-negative mutations of TBX18
as causing CAKUT. By employing TBX18 half-life estima-298 The American Journal of Human Genetics 97, 291–301, August 6tion, luciferase assay, and DNA interaction test by EMSA,
we demonstrate loss of function for three different muta-
tions in four families with CAKUT. Because TBX18 is
essential for developmental specification of the ureteric
mesenchyme and ureteric smooth muscle cells, we hereby
implicate ureter smooth muscle cell development in the
pathogenesis of human CAKUT.
TBX18 belongs to the T-box gene family, a large group
of transcription factors involved in many aspects of
embryonic development.29 In mice, Tbx18 has been
shown to be selectively expressed in ureteral mesenchyme
and to regulate ureteral smooth muscle differentiation.23
Mouse models lacking Tbx18 show malformed ureters
resulting in various types of obstructive uropathy
phenotypes as well as kidney parenchymal damage. The
latter was suggested to be secondary to urine outflow
obstruction,23 but TBX18 might also play a role during
kidney development.30 Similar to the heterogeneity of
kidney and urinary tract phenotypes previously seen in, 2015
Tbx18-deficient mice, the phenotypes we observed in
individuals with TBX18 mutations were broad and
heterogeneous with predominant obstructive uropathy
(Table 1).
Our findings support a dominant-negative effect of
defective TBX18 proteins on the wild-type protein. In
particular, we show that TBX18 altered proteins dimerize
with the wild-type TBX18, were nonfunctional by them-
selves, and when co-expressed with wild-type TBX18
showed a dominant-negative effect. Our findings are
consistent with the general consensus that proteins that
dimerize are particularly prone, when altered, to exert
dominant-negative effects by sequestering functioning
molecules into inactive dimers.
Tbx18-null mice die shortly after birth due to severe
malformations of the axial skeleton.31 In addition,
TBX18 was suggested to regulate the normal development
of the sinoatrial node.32,33 Consequently, Tbx18 gene
therapy was recently used for biological pacing in porcine
model of heart block.34 None of the individuals in the
current study presented with bone or heart malforma-
tions. Overall the phenotypes of the individuals with
dominant TBX18 mutations were milder when compared
to the severe Tbx18 recessive null mice phenotype. None-
theless, the dominant human phenotype was more severe
when compared to the phenotype of the heterozygous
mice that appear normal. This apparent discrepancy
might again be explained by a dominant-negative effect
in which specific heterozygous mutations cause more
severe effects than simple heterozygous null alleles of
the same gene.
When considering the anatomical location and devel-
opmental stage of TBX18 expression, we postulate that
the following mechanisms play a role in the pathogenesis
of TBX18 loss of function. Because our immunohisto-
chemistry data (Figure S3) as well as expression data
from the LacZ-Tbx18/þ mouse model23 demonstrate
that TBX18 is localized in the urinary system only in
the ureter and only during development of the urogenital
tract, the relevant pathogenic effect must act during ure-
ter development. Furthermore, because it was shown
that Tbx18 is expressed in the ureteric mesenchyme and
is required to prepattern the ureteric mesenchyme sub-
lineage, loss of Tbx18 function will interfere with proper
differentiation of the histologic layering of the ureter.22
It is therefore likely that the CAKUT phenotypes that
we observed in addition to obstructive uropathy in
individuals with TBX18 mutations, including renal
hypo/dysplasia, occur by loss of essential TBX18 function
during nephrogenesis.30 Alternatively, hypo/dysplasia
might develop in way of a ‘‘sequence,’’ in which lack
of urine transport in a maldeveloped ureter and the
resultant intrarenal pressure interferes with proper renal
development.13
Our discovery of dominant TBX18mutations as causing
human CAKUT via lack of repression of TBX18 transcrip-
tional activity for the first time implicates ureter smoothThe Amermuscle cell development in the pathogenesis of human
CAKUT.Supplemental Data
Supplemental Data include four figures and one table and can be
found with this article online at http://dx.doi.org/10.1016/j.
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